Arakawa Pharmaceuticals of Japan is promoting a new arthritis relief drug, citing results of a recent test. The test was conducted using five patients in a test group and five patients in a control group. Patients in the test group were given the new drug for six months, while patients in the control group were given a sugar pill. At the end of the experimental period, patients in each group were given a comprehensive test measuring freedom from pain. Test results are given below:

a. Review the hypothesis testing approach described in Chapter 10 for testing the difference between two population means using the t distribution. Use that hypothesis testing approach to determine if sample evidence here is sufficient to reject a €œno difference in population mean scores€ null hypothesis at the 5% significance level.
b. Use one-way analysis of variance to determine if there is sufficient sample evidence to reject the €œno difference€ null hypothesis at the 5% significance level.
c. Comment on the connection between the tstat and Fstat values that you produced in parts a and b.
d. Comment on the connection between the tc and Fc values that you used in parts a and b.
e. Comment on the connection between the pvalues that you produced in parts a and b.

Transcribed Image Text:

Test Group Control Group 79 75 84 70